Wolfgang Seemann-Schultze
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Repeated Renal Interventions for Renal Cell Carcinoma in von Hippel-Lindau Disease: Long-Term Outcomes.
Journal: European urology focus
Published: January 24, 2026
Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days' follow-up.
Journal: Prostate cancer and prostatic diseases
Published: February 11, 2021
Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers
Journal: Der Urologe. Ausg. A
Published: April 11, 2020
Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study.
Journal: Anticancer research
Published: September 28, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 08, 2018
Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 29, 2018
Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 04, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study.
Journal: European urology focus
Published: January 11, 2018
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 12, 2017
Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.
Journal: World journal of surgical oncology
Published: October 04, 2016
Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative Men.
Journal: BioMed research international
Published: August 29, 2016
Last Updated: 09/26/2026